CD9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.089600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.512400E-01
Normal-vs-Stage2
5.591800E-01
Normal-vs-Stage3
8.164400E-01
Normal-vs-Stage4
3.088000E-01
Stage1-vs-Stage2
2.110400E-02
Stage1-vs-Stage3
4.747000E-01
Stage1-vs-Stage4
6.139900E-02
Stage2-vs-Stage3
6.703600E-01
Stage2-vs-Stage4
8.948800E-01
Stage3-vs-Stage4
5.400200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.147400E-01
Normal-vs-AfricanAmerican
4.171800E-01
Normal-vs-Asian
7.397400E-01
Caucasian-vs-AfricanAmerican
8.484000E-01
Caucasian-vs-Asian
2.750200E-01
AfricanAmerican-vs-Asian
5.140000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.282400E-01
Normal-vs-Female
5.141200E-01
Male-vs-Female
4.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.080600E-01
Normal-vs-Age(41-60Yrs)
2.732400E-01
Normal-vs-Age(61-80Yrs)
7.097400E-01
Normal-vs-Age(81-100Yrs)
4.714600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.518360E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.893800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.465800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.124800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.828800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.571200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.926200E-01
Normal-vs-Daily Drinker
5.327600E-01
Normal-vs-Weekly Drinker
8.128200E-01
Normal-vs-Occasional Drinker
3.847800E-01
Normal-vs-Social Drinker
3.786000E-01
Non Drinker-vs-Daily Drinker
2.611400E-01
Non Drinker-vs-Weekly Drinker
1.971560E-01
Non Drinker-vs-Occasional Drinker
5.492600E-01
Non Drinker-vs-Social Drinker
5.999600E-01
Daily Drinker-vs-Weekly Drinker
6.082000E-01
Daily Drinker-vs-Occasional Drinker
3.045800E-01
Daily Drinker-vs-Social Drinker
2.725600E-01
Weekly Drinker-vs-Occasional Drinker
2.361400E-01
Weekly Drinker-vs-Social Drinker
2.251400E-01
Occasional Drinker-vs-Social Drinker
9.187800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.795500E-03
Normal-vs-Grade 2
1.62470037423645E-12
Normal-vs-Grade 3
2.738400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.102000E-01
Grade 1-vs-Grade 3
6.692800E-01
Grade 1-vs-Grade 4
6.795500E-03
Grade 2-vs-Grade 3
4.338200E-01
Grade 2-vs-Grade 4
1.62470037423645E-12
Grade 3-vs-Grade 4
2.738400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.465800E-01
Normal-vs-NonDiabetic
4.998200E-01
Diabetic-vs-NonDiabetic
5.189600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.426800E-01
Normal-vs-NoPancreatitis
6.261800E-01
Pancreatitis-vs-NoPancreatitis
4.648000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.177800E-01
Normal-vs-N1
5.440000E-01
N0-vs-N1
6.149600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.555400E-01
Normal-vs-TP53-NonMutant
7.964400E-01
TP53-Mutant-vs-TP53-NonMutant
2.684400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
